Joseph S Zakrzewski is of AN2 Therapeutics, Inc.. Currently has a direct ownership of 125,199 shares of ANTX, which is worth approximately $157,750. The most recent transaction as insider was on Nov 27, 2024, when has been sold 2,000 shares (Common Stock) at a price of $1.4 per share, resulting in proceeds of $2,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 125K
27.5% 3M change
27.5% 12M change
Total Value Held $157,750

Joseph S Zakrzewski Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 27 2024
BUY
Open market or private purchase
$2,800 $1.4 p/Share
2,000 Added 1.57%
125,199 Common Stock
Nov 19 2024
BUY
Open market or private purchase
$5,050 $1.01 p/Share
5,000 Added 3.9%
123,199 Common Stock
Nov 18 2024
BUY
Open market or private purchase
$20,000 $1.0 p/Share
20,000 Added 14.47%
118,199 Common Stock
Mar 29 2022
BUY
Conversion of derivative security
-
98,199 Added 50.0%
98,199 Common Stock

Also insider at

AMRN
AMARIN CORP PLCUK Healthcare
XLRN
ACCELERON PHARMA INC Healthcare
SGMO
SANGAMO THERAPEUTICS, INC Healthcare
CYT
Cyteir Therapeutics, Inc. Healthcare
JSZ

Joseph S Zakrzewski

Brisbane, CA

Track Institutional and Insider Activities on ANTX

Follow AN2 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANTX shares.

Notify only if

Insider Trading

Get notified when an An2 Therapeutics, Inc. insider buys or sells ANTX shares.

Notify only if

News

Receive news related to AN2 Therapeutics, Inc.

Track Activities on ANTX